Proud to share that our human clinical trial on CBD and immune function is now published!
Led by Dr. Michael Eadon (Clinical Pharmacology Division, Indiana University School of Medicine) and honored to contribute as author.
This is the 5th paper from this clinical trial.
Cannabidiol is used off-label for chronic pain, yet little is known about its immune system effects in transplant recipients.
Here, ASCI member Gisch et al. report CBD exerts anti-inflammatory effects but maintains T effector memory cell differentiation in humans: doi.org/10.1172/jci....
